Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Multimodal electroconductive PLGA-based scaffold orchestrates neuroprotection and regeneration following severe spinal cord injury

Park SY., Kim G., Liu Y., Jung JW., Lee JE., Lee JK.

Animal Study on Spinal Cord Injury, Scar, Chronic Inflammation, published in J Nanobiotechnology (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
J Nanobiotechnology (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41507980
PMCID
PMC12794284
DOI
10.1186/s12951-025-03998-4
Citations
2

Abstract (original English)

Spinal cord injury (SCI) is a devastating neurological condition that has limited therapeutic options; thus, developing innovative regenerative strategies to treat SCI is necessary. This study presents a multifunctional scaffold system that synergistically combines poly(lactic-co-glycolic acid) and multiple bioactive components such as magnesium hydroxide nanoparticles, decellularized brain extracellular matrix, two-dimensional MXene nanosheets, berberine, sertoli cell-derived extracellular vesicles, and neural progenitor cells. This synergistic design provides a bioactive microenvironment that mitigates inflammation and promotes antioxidative responses while delivering sustained bioactive signals for neural repair. In particular, the conductive property of the scaffold resulting from MXene incorporation facilitates intercellular electrical signaling to provide axonal regeneration. In vitro, the scaffold modulates macrophage polarization toward an anti-inflammatory M2 phenotype, promotes neural differentiation, and reduces oxidative stress. In a complete transection rat model, the scaffold enhances motor function recovery and reduces neuropathic pain. Histological analyses show reduced glial scar formation, enhanced remyelination, and robust axonal regeneration. Molecular studies further confirm the upregulation of anti-inflammatory cytokines and neurotrophic factors, thereby d

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsRatsRats, Sprague-DawleySpinal Cord InjuriesNerve RegenerationMaleTissue ScaffoldsNeuroprotectionPolylactic Acid-Polyglycolic Acid Copolymer

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research